Synthesis and Biological Screening of Some New Series of Aryl Thiazole Derivatives

 

*Raga Basawaraj  and  Majid Shabbir

Post-Graduate Centre, Dept.of Pharmaceutical Chemistry, Karnataka College of Pharmacy, Manahalli Road, Bidar-585403

*Corresponding Author E-mail: ragabv@rediffmail.com

 

 

ABSTRACT

2-Arylamino/arylidinehydrazino-4-(4-methoxyphenyl-2-yl) thiazoles were obtained by the reaction of 1-bromoacetyl-4-methoxyphenyl with various substituted arylthioureas and arylidinethiosemicarbazides in ethanol. Aminogroup of aryl thiazole have been treated with different aromatic aldehydes afford corresponding schiff bases, which on further treated with chloroacetylchloride and mercaptoacetic acid converted to corresponding azetidinones and thiazolidinones. All the compounds were characterized on basis of analytical and spectral data and these compounds were screened for invitro antimicrobial activity.

 

KEYWORDS : Arylthiazole, Schiff’s bases, Azetidinones, Thiazolidinones, Antimicrobial activity.

 


 

INTRODUCTION:

Thiazole and its derivatives have been associated with a wide variety of biological and  pharmacological activity1-2. The 2-aminothiazole-ring system has found application in the drug development for the treatment of HIV infection, allergy, hypertension and inflammation3. Thiazole derivatives are also well known for their bactericidal, fungicidal and anthehelmintic properties4. Further many azetidinone and thiazolidinone derivatives were also reported for their antimicrobial agents5.

 

Taking these views in to consideration and in continuation of our research work on the synthesis of biologically active agents6-8 and it was thought of interest to synthesized several arylthiazole derivatives possessing azetidinone and thiazolidinone moieties with the interest to possess better antimicrobial activity.

 

In the present course of study, 1-bromoacetyl-4-methoxyphenyl 2 was used as starting material for the synthesis of above titled compounds and it was synthesized by the bromination of 4-methoxy acetophenone 1 with bromine in acetic acid.

 

The reaction of compound 2 with various substituted arylthiourease in anhydrous ethanol at reflux temperature for 3hrs gave 2-arylamino-4-(4-methoxyphenyl-2-yl)thiazoles 2a-d in good yields.

 

Similarly the reaction of 2 with substituted arylidine thiosemicarbazides8 in anhydrous ethanol at boiling temperature for 3hr furnished 2-arylidinehydrazino-4-(4-methoxyphenyl-2-yl)thiazoles 3a-d.

 

The interaction of 1-bromoacetyl-4-methoxyphenyl 2 with the thiourea in ethanol to gave 2-amino-4-(4-methoxyphenyl-1-yl)thiazole 4. Compound 4 was treated with various aromatic aldehydes in boiling ethanol to get 2-[(substituted arylidine)amino]-4-(4-methoxyphenyl-1-yl)thiazoles(schiff’s bases) 4a-e. These compounds 4a-e on further reaction with chloroacetylchloride and mercaptoacetic acid produced 3-chloro-4-(substituted phenyl)-1-[4-(4-methoxyphenyl)-1, 3-thiazol-2-yl]azitidin-2-ones 5a-e and 3-[4-(4-methoxyphenyl)-1, 3-thiazol-2-yl]-2-substituted phenyl 1, 3-thiazolidine-4-ones  6a-e (Scheme-1).

 

The structures of all newly prepared arylthiazole derivatives were established on the basis of spectral and analytical data and these compounds were evaluated for their antibacterial, antifungal activities and some selected compounds were determined for their pharmacological studies.

 

Antimicrobial activity

The invitro antimicrobial activity of synthesized compounds were determined by using  Cup-plate diffusion method9. The organisms selected for antibacterial activity are S.epidermiitatis and Escherichia coli and for antifungal activity Aspergillus niger and Candida albicans. These organisms were procured from the Department of Microbiology, Gulbarga University, Gulbarga. The Ciprofloxacin and Fluconazole were used as standard drugs for antibacterial and antifungal activity respectively. The test compounds and standard drugs were used at the concentration of 100μ/0.1ml.

 

Amongst the tested compounds 2c, 3e, 5b, 4b, 5e and 6e have shown high antibacterial activity against S.epidermitatis and E.coli where as compounds 3a, 3d, 4e, 5c and 6b exhibited moderate activity against both bacteria.

 


 


Compounds 2c, 3c, 5b, 5d and 6e were exhibited good antifungal activity against A.niger and Candidica albicans. Compounds 3b, 3d, 4e, 6c and 6d showed moderate  activity against  Aspergillus niger and Candida albicans and remaining compounds showed moderate to weak activity against both fungi.

 

MATERIALS AND METHODS:

Melting points of all compounds were determined by open capillaries and are uncorrected and the purity of all synthesized compounds were checked using TLC on silica gel plates. The IR Spectra (KBr) cm-1 were recorded on FTIR-8400S (Shimadzu) Spectrometer. 1HNMR Spectra (CDCl3) were recorded on ACF 200Supercone Switzerland NMR Spectrophotometer and mass spectra were recorded on LC-MS 2010A(SHIMADZU)mass spectrophotometer using TMS as internal standards and expressed in d(ppm).

 

1-Bromoacetyl-4-methoxyphenyl (2)

A solution of 4-methoxyacetophenone 1 (0.02mole) in acetic acid (100ml) was added to bromine(0.18mole) in acetic acid. The reaction mixture kept at room temperature for 5hr . Then it was poured in to ice cold water, the solid separated was collected and crystallized from ethanol.

 

IR(KBr)cm-1 1439, 1506, 1599(C=C str), 1678(C=O), 2937(C-Hstr OCH3). 1HNMR (CDCl3) d 3.8(s, 3H, OCH3), 4.4(s, 2H, CH2), 7.8(m, Ar-H), mass spectra m/z  231(M+, 100%), 151, 127, 71.

 

2-Arylamino-4-(4-methoxyphenyl-2-yl)thiazoles (2a-d)8

 

General procedure

A mixture of 1-bromoacetyl-4-methoxy phenyl 2 (0.002mole) in anhydrous ethanol (10ml) and substituted thiourea (0.002mole) and the reaction mixture was refluxed for 3hr. After cooling the mixture was poured in to water and neutralized with aqueous sodium acetate solution(5% w/v), the solid separated was collected and purified by recrystallised using suitable solvent system.

 

2a: IR (KBr) cm-1 3100 (N-Hstr), 1601 (C=N), 2934(C-Hstr OCH3). 1HNMR (CDCl3) d 3.8 ( s, 3H, OCH3),  6.6 ( s, 1H, thiazole),  6.4-7.4 ( m, Ar-H ),  7.6 (s, 1H, NH). Mass Spectra m/z 301(M-1, 289, 771, 209, 166, 120.

 

2b:, IR (KBr) cm-1 2922 (CHstr, OCH3), 1601 (C=N), 3166(N-Hstr). 1HNMR (CDCl3) d 1.3( s, 3H, CH3),  3.8 ( s, 3H, OCH3),  6.6(s, 1H, thiazole),  6.8-7.3(m, Ar-H)  7.7 (s, 1H, NH). Mass Spectra m/z 297(M+1, 100%).

 

2c: IR (KBr) cm-1 1610 (C=N),  2930(C-Hstr,OCH3), 3170 (N-Hstr).1HNMR (CDCl3) d 3.8 ( s, 3H, OCH3),  6.5 ( s, 1H, thiazole),  6.7-7.4 ( m Ar-H),  7.6 (s, 1H, NH). 

 

2-Arylidene hydrazine-4-(4-methoxy Phenyl-2-yl) thiazoles (3a-e)8

 

General Procedure:

To a solution of 1-bromoacetyl-4-methoxy phenyl (0.002mol) 2 in anhydrous ethanol (10ml) was added arylidenethiosemicarbazide IIa-e (0.002mol) in anhydrous ethanol (15ml) and the reaction mixture was refluxed for 3hr. After cooling the reaction mixture was poured into water and neutralized with aqueous sodium acetate (5% w/v). The solid separated was collected and crystallized from suitable solvent.

 

3a: IR (KBr) cm-1 1612 (C=N),  2930(C-Hstr,OCH3), 3180 (N-Hstr).1HNMR (CDCl3) d 3.8 ( s, 3H, OCH3),  6.5 ( s, 1H, thiazole),  6.7-7.4 (m, Ar-H),  7.6 (s, 1H, NH), 10.8(s, 1H, -N=CH). Mass Spectra m/z 301(M+, 289).

 

3b: IR (KBr) cm-1 1605 (C=N), 2930 (C-Hstr, OCH3), 3180(N-Hstr). 1HNMR (CDCl3) d 3.8( s, 3H, OCH3),  10.2 ( s, 1H, OH),  6.7 (s, 1H, thiazole),  7.0-8.1(m, Ar-H) . 8.8 ( s, 1H, NH),  11.0 (s, 1H, -N=CH). Mass Spectra m/z 326(M+, 100%), 241(25%), 279(10%), 253 (5%), 207(5%), 193(8%), 122(5%), 77(2%).

3c:  IR (KBr) cm-1 1601 (C=N), 2927(C-Hstr, OCH3), 3383(N-Hstr). 1HNMR (CDCl3) d 3.9( s, 3H, OCH3),  10.3 ( s, 1H, OH),  6.5 (s, 1H, thiazole),  6.9-7.5( m, Ar-H ),  8.5 ( s, 1H, NH),  11.0 (s, 1H, -N=CH). Mass Spectra m/z 326(M+, 100%).

 

2-Amino-4-(4-methoxy-2-phenyl)Thiazole (4)

General procedure:-

To a solution of 1-bromoacetyl-4-methoxy phenyl (0.002 mole) 2 in anhydrous ethanol (10ml) was added thiourea (0.002mol). the reaction mixture was refluxed for 3hr. after cooling the reaction mixture was decomposed in ice cold water and neutralized with aqueous sodium acetate solution (5% w/v), the solid separated was collected and recrystallised  from ethanol. IR(KBr) Yield: 70%, m.p 1820C. IR (KBr) cm-1 1620 (C=N), 2927(C-Hstr, OCH3), 3100-3383(N-Hstr, NH2). 1HNMR (CDCl3) d 3.9( s, 3H, OCH3),   6.8 (s, 1H, thiazole),  7.2-7.6( m, Ar-H ). Mass Spectra m/z  326(M+, 100%), 189(10%), 140(20%) and 71(5%).

 

2-[(substituted arylidene)amino]-4-(4-methoxyphenyl-1-yl) thiazoles  (Schiff bases) (4a-e).

General procedure:-

A mixture of 4 (0.01mol) and various aromatic aldehydes (0.01mol) in ethanol (40ml) along with glacial acetic acid (2-3drops). The reaction mixture was refluxed for 3hrs, cooled. Thus solid separated was washed with ethanol and purification was carried out using suitable solvent.

 4a: IR (KBr) cm-1 1600 (C=N), 2973(C-Hstr.OCH3). 1HNMR (CDCl3) d 3.8( s, 3H, OCH3),   6.8 (s, 1H, thiazole),  7.2-7.6( m, Ar-H ), 10.9(s, 1H, -N=CH).

 

3-chloro-4-(substituted phenyl)-1-[4-(4-methoxyphenyl)-1, 3-Thiazol-2-yl]azitidin-2-ones  (5a-e).

 

General procedure:-

A ethanolic solution of compound 4a-e (0.01mol), choroacetylchoride (0.01mol) was added drop wise with constant starring in presence of triethylamine (0.01mol) at 0-50C. The reaction mixture was refluxed for 8hrs. After completion of reaction excess of ethanol distilled off. The resulting residual mass cooled, poured into ice water, filtered, washed with water, dried and recrystallised from suitable solvent ethanol to yield compound 5a-e.

 


Table-1 Characterization data of synthesized compounds

Compound

R

M.P (0C)

Yield (%)

Molecular  formula

Solvent for crystallization

2a

C6H5

92

61

C16H14N2OS

Ethanol

2b

C6H4CH3(p)

110

67

C17H16N2OS

Ethanol

2c

C6H4Cl(p)

118

60

C16H13N2OS

Ethanol

2d

C6H4F(p)

100

65

C16H13FN2OS

Ethanol

3a

C6H5

102

62

C17H15N3OS

Ethanol

3b

C6H4OH(o)

128

68

C17H15N3O2S

Ethanol

3c

C6H4OH(p)

100

68

C17H15N3O2S

Ethanol

3d

C6H4OCH3(p)

95

63

C18H17N3O2S

Ethanol

3e

C6H4Cl(p)

90

65

C17H14ClN3O2S

Ethanol

4a

C6H5

220

62

C17H14N2OS

Ethanol

4b

C6H4OH(o)

120

68

C17H14N2O2S

Ethanol

4c

C6H4OH(p)

85

68

C17H14N2O2S

Ethanol

4d

C6H4OCH3(p)

82

63

C18H16N2O2S

Ethanol

4e

C6H4Cl(p)

102

65

C17H13ClN2OS

Ethanol

5a

C6H5

230

52

C19H15ClN2O2S

Ethanol

5b

C6H4OH(o)

170

58

C19H15ClN2O3S

Ethanol

5c

C6H4OH(p)

125

60

C19H15ClN2O3S

Ethanol

5d

C6H4OCH3(p)

165

63

C20H17ClN2O3S

Ethanol

5e

C6H4Cl(p)

155

55

C19H14ClN2O2S

Ethanol

6a

C6H5

115

62

C19H16N2O2S

Ethanol

6b

C6H4OH(o)

220

57

C19H16N2O3S

Ethanol

6c

C6H4OH(p)

135

60

C19H16N2O3S

Ethanol

6d

C6H4OCH3(p)

110

53

C20H18N2O3S2

Ethanol

6e

C6H4Cl(p)

205

59

C19H15N2O2S2

Ethanol

All the compounds were shown C, H and N analysis satisfactory

 

Table-2 Antimicrobial activity of synthesized compounds

Compound

Zone of inhibition in mm

      Antibacterial                                                        Antifungal

S. epidermatitis     E. coli

A.niger       C.albicans

Control(DMF)

8                             8

8                                   8

Standard

Ciprofloxacin

Fluconazole

 

23                                24

  -                                  -

 

-                                                -

25                                 24

2a

17                                13

17                                 14

2b

15                                17

16                                 13

2c

21                                18

23                                 22

2d

22                                20

21                                 20

3a

16                                18

17                                 13

3b

11                                13

16                                 18

3c

21                                17

22                                 21

3d

16                                 17

21                                  17

3e

22                                 22

17                                  18

4

11                                 14

16                                  14

4a

11                                 10

16                                  13

4b

21                                 19

20                                  17

4c

20                                 20

16                                  17

4d

16                                 13

20                                  18

4e

15                                 17

21                                  16

5a

12                                 13

21                                  17

5b

22                                 21

20                                  21

5c

18                                 17

18                                  19

5d

22                                 16

20                                  22

5e

23                                  22

22                                  21

6a

14                                  15

12                                  13

6b

15                                  16

18                                  19

6c

16                                  17

17                                  18

6d

14                                  15

16                                  17

6e

20                                   21

20                                  23

*Diameter of the well 8mm


 

5a:, IR (KBr) cm-1 1607 (C=N), 2973(C-Hstr, OCH3), 1701(C=O). 1HNMR(CDCl3) d 1.0( d, 1H,-CH-ph,azetidine), 3.2 (d, 1H, CH-Cl, azetidine),  3.8( s, 3H, OCH3),  6.5-7.2(m, Ar-H) .

 

5d: IR (KBr) cm-1 1178(C-S),1610(C=N), 2923(C-Hstr, OCH3), 1325 (C-N), 1701(C=O).

 

1HNMR (CDCl3)d 1.0( d, 1H,-CH-ph, azetidine), 3.3 (d, 1H, CH-Cl azetidine) 3.8( s, 3H, OCH3),   6.6( s, 1H, thiazole), 


 

6.4-7.3( m,  Ar-H ) .Mass Spectra m/z 461(m+, 100%), 379, 350, 290, 271, 229, 185, 165, 115.

 

3-[4-(4-methoxyphenyl)-1, 3-thiazol-2-yl]-2-substituted phenyl 1,3-thiazolidine-4-ones  (6a-e)

General procedure:-

 

To a solution of compound 4a-e (0.01mol) in methanol (50ml), thioglycollic acid (0.02mol) was added dropwise in presence of anhydrous zinc chloride and this reaction.

mixture was refluxed for 8hrs. After completion of reaction excess of ethanol distilled off. The resulting residual mass cooled, poured into ice water, filtered, washed with water, dried and recrystallised from suitable solvent.

 

6c: IR (KBr) cm-1  1178(C-S), 1396(C-N), 1630(C=N), 2923(C-Hstr, OCH3), 1740(C=O) 3402(OH). 1HNMR (CDCl3)d  4.4( s, 2H,-CH2), 4.8(s, 1H, Ph-thiazolidinone),  3.8( s, 3H, OCH3),  6.6 (s, 1H, thiazole), d6.4-6.8( m,   Ar-H), 10.2(s, 1H, OH). Mass Spectra m/z 463(M+, 100%)

6d: IR (KBr) cm-1 1390(C-N),  1627(C=N), 2923(C-Hstr, OCH3), 1396 (C-N), 1741(C=O) 3400(O-H).  1HNMR d 4.4( s, 2H, -CH2), 4.9(s,1H, Ph-thiazolidinone),  6.6 (s, 1H, thiazole),  6.4-6.8 ( m, Ar-H) .Mass Spectra m/z 399(M+ 100), 379(60%), 320(38%), 290(46%), 251(28%), 229(15%), 195(80%), 169(25%), 119(10%).

 

RESULTS AND DISCUSSION

Thiazole and its derivatives have been associated with its wide range of its biological and pharmacological properties. The arylthiazole derivatives (2a-d) and (3a-e) were synthesized by the reaction of 1-bromoacetyl-4-methoxyphenyl 2 with substituted thiourea and arylidinethiosemicarbazide in ethanol at refluxed temperature. The reaction of  2-amino-4-(4-methoxy-2-phenyl)thiazole (4) with various substituted aromatic aldehydes in ethanol in presence of catalytic quantity of glacial acetic acid to obtained corresponding schiff’s bases (4a-e) which further underwent cyclisation upon treatment with chloroacetylchloride in presence of triethylamine and thioglycollic acid in presence of anhydrous zinc chloride  to afforded 3-chloro-4-(substituted phenyl)-1-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl)azitidin-2-ones (5a-e) and 3-[4-(4-methoxyphenyl)-1,3-thizol-2-yl]-2-substituted phenyl-1,3-thiazolidine-4-ones respectively (6a-e).

 

All synthesized compounds were purified by crystallization method and its  purity was checked by TLC with suitable solvent system. The structures of all prepared compounds were established by using IR, 1HNMR, mass spectra and analytical data. These compounds were screened for their antibacterial and antifungal activities and some of the compounds were exhibited good antibacterial and antifungal activity.

 

ACKNOWLEDGEMENT

The authors wish to express their sincere thanks to Sirse Krantikumar, Principal, Karnataka college of pharmacy Bidar and Channabasappa hallahali, president, management members of K.R.E. society’s Bidar for help during our research work. Thanks to Central University, Hyderabad for providing 1HNMR and mass spectral data.

 

REFERENCES:

1.        Metzer AY, KatritzkyAR  and Rees CW, “ Comprehensive Heterocyclic Chemistry “ eds. Pergamon, New York. 1984; 32: 6.

2.        Katritzky AR and Rees CW“Comprehensive Heterocyclic Chemistry “ eds. Pergamon, New York, 1982;233:6.

3.        Pattan SR  , Shamerz Ali M , Pattan JS, Purohit SS, Reddy VVK  and Nataraj BR .Synthesis and microbiological evaluation of 2-acetanilido-4-arylthiazole derivatives.  Indian J.Chem., 2006;45B:1929-1932.

4.        Kalluraya B, Rahiman AM, Isloor AM, Priya V and Jagadeesha RL. Synthesis and pharmacological activity of some-4-(substituted)-2-[4-arylhydrazono-3-methyl-5-oxo-2-pyrazolin-1-yl]thiazoles. Indian J.Heterocyclic Chem.2004; 13:245-248.

5.        L.Jaish and S.K.Srivastava,  Chem Absr, 136(5), 805 (2000).

6.         Basawaraj R, Parameshwarappa G and Sangapure SS. Synthesis and biological evaluation of some new benzofuran derivatives. Indian Drugs. 2007;44(1):8-12.

7.         Basawaraj R , Suresh M and Sangapure SS.Synthesis and pharmacological activities of some 2-arylamino/arylidene hydrazine-4-(5’-chloro-3’-methylbenzofuran-2’-yl)thiazoles. Indian J. Heterocycl.Chem., 15,153(2005;15:153-156

8.         Basawaraj R  and Sangapure SS. Synthesis of some 3-aryl-2-(5’-chloro-3’methylbenzofuran-2’-yl)-1,4-quinoxalylmethanes of biological interest. Int.J.Chem.Sci.2008; 6(1)351-357.

9.        Indian Pharmacopoeia., Controller of publication New Dehli..1996; 11

 

 

 

Received on 04.06.2009        Modified on 08.08.2009

Accepted on 13.09.2009        © AJRC All right reserved

Asian J. Research Chem. 2(4):Oct.-Dec. 2009 page 440-444